4 completed, 2 terminated, 1 withdrawn. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Withdrawn 1 |
| Phase 1 | 3 | Terminated 2, Completed 1 |
Follow AbGenomics B.V Taiwan Branch: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer AbGn-107 - Gastric Cancer, Colorectal Cancer | Phase 1 | Terminated | AbGenomics B.V Taiwan Branch | 39 | 2017-04-24 | 2021-07-13 |
| A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD Neihulizumab Treatment, Conventional Treatment - Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation | Phase 2 | Withdrawn | AbGenomics B.V Taiwan Branch | 2016-07-01 | 2016-04-25 | |
| A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant AbGn-168H - Acute Graft Versus Host Disease | Phase 1 | Terminated | AbGenomics B.V Taiwan Branch | 4 | 2015-05-01 | 2017-03-30 |
| A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis AbGn-168H - Psoriatic Arthritis | Phase 2 | Completed | AbGenomics B.V Taiwan Branch | 20 | 2015-01-01 | 2017-01-24 |
| A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis AbGn-168H, Placebo - Moderate to Severe Chronic Plaque Psoriasis | Phase 2 | Completed | AbGenomics B.V Taiwan Branch | 50 | 2014-05-01 | 2016-04-14 |
| Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients AbGn-168H, placebo - Moderate to Severe Chronic Plaque Psoriasis | Phase 2 | Completed | AbGenomics B.V Taiwan Branch | 54 | 2013-05-01 | 2015-05-08 |
| An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors AbGn-7 - Solid Tumor of Epithelial Origin, Gastric Cancer | Phase 1 | Completed | AbGenomics B.V Taiwan Branch | 13 | 2011-11-01 | 2015-06-23 |
Neoplasms (2) · Psoriasis (2) · Stomach Neoplasms (2) · Adenocarcinoma (1) · Arthritis, Psoriatic (1) · Biliary Tract Neoplasms (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Pancreatic Neoplasms (1)
United States (7) · Taiwan (2)
Shih-Yao Lin, MD, PhD (4) · Mark Lebwohl, MD (2) · Andrew Ko, MD (1) · Anthony Olaszanski, MD, RPh (1) · Devalingham Mahalingam, MD (1) · Everett Meyer, MD (1) · Kuen-Hui Yeh, MD (1) · Mark Genovese, MD (1) · Ruey-Kuen Hsieh, MD (1) · Shih-Yao Lin, MD, Ph.D (1)